Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been newly diagnosed with hormone receptor positive, HER2 negative invasive breast cancer, or a specific early form called DCIS with microinvasion, confirmed by a tissue sample (biopsy).
- People who are postmenopausal and older than 55 years of age.
- People whose main breast tumour is no larger than 3 cm and whose underarm (axillary) lymph nodes show no signs of cancer involvement, both on physical examination and on an ultrasound scan performed at Clinical Hospital Centre Rijeka.
- People for whom doctors have determined that breast-conserving surgery (removing the tumour while keeping the breast) and follow-up radiation treatment to the whole breast are suitable options.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are younger than 55 years of age and/or are premenopausal, or who have confirmed cancer spread to the underarm lymph nodes, or who have multiple suspicious lymph nodes on underarm ultrasound.
- People diagnosed with pure DCIS (a very early, non-invasive form of breast cancer) where there is no focal invasion at all.
- People whose tumour is larger than 3 cm, or whose cancer has spread to the chest wall or skin (known as cT4), or who have been diagnosed with cancer that has already spread to other parts of the body (metastatic disease).
- People whose breast cancer is classified as HER2 positive or triple-negative (specific tumour types determined by laboratory testing).
- People who have already received any form of drug treatment (such as chemotherapy or hormone therapy) before surgery, or who have a personal history of invasive breast cancer in the past.
- People with breast cancer that has spread across a large area of the breast or in multiple separate areas, people for whom mastectomy (full breast removal) or partial breast radiation is planned, or people who decline the recommended drug treatment after surgery.
- People who do not wish to take part in a clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0038551658120
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Isolated regional recurrence free survival; Disease free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.